NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»21/12/2009 [Company watch]
Covance Expands Offices in Japan and Hong Kong

Covance Inc. today announced the opening of new clinical development offices in Seoul, South Korea and Mumbai, India and office expansions in Tokyo, Japan and Hong Kong, China to accommodate growing demand for clinical development services in Asia-Pacific.

Covance Opens New Clinical Development Offices in South Korea and India; Expands Offices in Japan and Hong Kong --Expands Offices in Japan and Hong Kong help biopharmaceutical clients reduce drug development timelines -- Covance has provided clinical trial support in Asia-Pacific for more than two decades, starting with offices in Australia and then Singapore. Operations expanded quickly with the set up of a clinical development office in Beijing, China and a second office in Shanghai, offering both clinical and central laboratory services. The new clinical development office in Seoul will help Covance further increase patient access in the region, while supporting its regional network of field-based CRAs throughout Asia-Pacific. The new Mumbai office will function as the main clinical trial support hub for the Indian sub-continent. Covance also expanded existing clinical development offices in Hong Kong and Tokyo, Japan to increase service capacity. The Tokyo office expansion provides additional capacity for both clinical development and central laboratory services, including sales, administration, and kit customization for the Japanese market. \"Our new Asia-Pacific offices support our global expansion strategy, which targets the most qualified investigators and appropriate patient populations in a region that is increasingly important to clinical trials,\" said Nick Wright, vice president and general manager, clinical development services Asia-Pacific, Covance. \"These offices will help us increase our clients\' Phase II/III clinical trial productivity by providing additional capacity to execute clinical studies with a full range of services.\" \"Covance is committed to delivering outstanding drug development services and building deeper strategic relationships with our clients,\" said Rick Cimino, president, clinical development services, Covance. \"To enable us to meet this commitment and provide more effective clinical trial solutions, we have significantly expanded our presence in emerging markets in 2009 by opening nine new offices in Asia Pacific, Latin America, and Eastern Europe.\" Covance offers clinical development services in 55 countries, including emerging markets across Asia-Pacific, Central and Eastern Europe, and Latin America. With a full suite of services to take a drug through all stages of development, Covance offers extensive clinical and therapeutic expertise, global reach, proactive project management, and strong investigator site relationships to consistently deliver high quality data on time.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.